NatWest Group’s Bristol-Myers Squibb BMY Stock Holding History

NatWest Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-52,495	Closed	-$3.11M	–	159
2015 Q3	$3.11M	Sell	52,495 -1,904	-4%	-$121K	0.07%	127
2015 Q2	$3.62M	Sell	54,399 -1,095	-2%	-$72.2K	0.05%	125
2015 Q1	$3.58M	Sell	55,494 -4,363	-7%	-$273K	0.05%	139
2014 Q4	$3.53K	Sell	59,857 -479	-0.8%	-$27K	0.03%	140
2014 Q3	$3.09K	Sell	60,336 -159	-0.3%	-$7.94K	0.03%	159
2014 Q2	$2.94M	Sell	60,495 -61,524	-50%	-$3.03M	0.12%	157
2014 Q1	$6.34M	Sell	122,019 -189,201	-61%	-$10.1M	0.28%	105
2013 Q4	$16.5M	Buy	311,220 +54,179	+21%	+$2.76M	0.42%	56
2013 Q3	$11.9M	Buy	257,041 +12,077	+5%	+$530K	0.35%	68
2013 Q2	$10.9M	Buy	+244,964	New	+$10.6M	0.16%	113

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

NatWest Group's BMY Position: Q4 2015 in Review

NatWest Group sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 52,495 shares — an estimated $3.11M sold.

NatWest Group first reported a position in BMY in Q2 2013 and held it in 10 quarters. The position peaked at $16.5M in Q4 2013. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

NatWest Group reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 52,495 Bristol-Myers Squibb shares in Q4 2015, an estimated $3.11M.
NatWest Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 10 quarters.
NatWest Group's Bristol-Myers Squibb position peaked at $16.5M in Q4 2013.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.